Retraction Watch

Tracking retractions as a window into the scientific process

Archive for the ‘china retractions’ Category

Yikes: Peer reviewer stole (and published) author’s data

with 2 comments

A gastroenterology and hepatology journal has retracted a 2017 review after discovering it included data “accessible only during peer review for another journal.”

Although we don’t know the details of this particular case—for instance, how the editors and publisher of Alimentary Pharmacology & Therapeutics learned about the transgression and which author was responsible—the journal acted quickly to retract the paper, which was published online in March.

Here’s the retraction notice for “Systematic review: benefits and harms of transarterial embolisation for treating hepatocellular adenoma:”

Read the rest of this entry »

Paper with duplicated image “sequentially builds” on neuroscience work, authors argue

without comments

A neurochemistry journal has retracted a paper from a group in China over a duplicated image.

According to the notice, the authors used the same image in the two papers to represent different experimental conditions. The only distinguishing feature between the images: “apparent brightness changes.”

The authors defended their actions, explaining that the research published in Journal of Neurochemistry “sequentially builds” on their previous study in Journal of Neuroinflammation, which they mention in the 2015 paper’s discussion. In the notice, the authors were quoted saying:  Read the rest of this entry »

Author retracts nanotechnology paper over doubts about key results

without comments

The corresponding author of a 2015 nanotechnology paper has penned a lengthy — and revealing — retraction notice, explaining why he is not certain about the findings.

In the notice, Chang Ming Li from the Institute for Clean Energy & Advanced Materials (ICEAM) at Southwest University in China, states that there is “insufficient evidence to conclusively” identify the composition of the nanowire array described in the article, which “severely undermines the validity of the reported conclusions.”

The 2015 paper has been considered “highly cited” by Clarivate Analytics’ Web of Science, formerly part of Thomson Reuters, meaning it has received a disproportionate amount of cites given its field and publication year.

Li also said that the paper — which appeared in Physical Chemistry, Chemical Physics — was “submitted and published without my knowledge or permission.” He has not responded to our request to explain how that could have happened, given that he was the corresponding author. Read the rest of this entry »

Four in 10 biomedical papers out of China are tainted by misconduct, says new survey

without comments

Chinese biomedical researchers estimate that 40% of research in their country has been affected in some way by misconduct, according to a new survey.

The authors are quick to caution against putting too much stock in this figure due to the subjective nature of the survey, published in Science and Engineering Ethics. The estimates also spanned a wide range, with a standard deviation of ±24%. But they say that the responses to this question and others on the survey suggest that scientists in the region feel academic misconduct remains a major problem that authorities have failed to adequately address. (Indeed, a recent analysis from Quartz using Retraction Watch data showed that researchers based in China publish more papers retracted for fake peer reviews than all other countries put together.)

The survey was designed by employees at Medjaden, a Hong Kong-based editing company that assists mainland Chinese biomedical researchers publishing in English-language journals. They invited all of their registered users by email to complete two surveys—roughly 10,000 users in 2010 and 15,000 in 2015. Like most online surveys, this one had a low response rate—around 5%, so caveats about sampling bias apply.

Study co-author Hua He, who is also Medjaden’s CEO, said:

Read the rest of this entry »

Written by Mark Zastrow

May 18th, 2017 at 9:30 am

Journal: Here’s why we didn’t retract this duplicated paper

with 2 comments

Here’s something we don’t see every day: A journal explains in an erratum notice why it chose not to retract a paper that contains data published elsewhere.

According to the Journal of Business and Psychology, the authors violated the journal’s transparency policy by failing to disclose that they’d used the same data in their 2014 in three others. However, the editors ultimately concluded the current paper was different enough from the other three to save it from being retracted.

Here’s the erratum: Read the rest of this entry »

Idea theft: Two food chemistry papers retracted for using someone’s ideas

without comments

A researcher has retracted two papers after her former supervisor complained she had used his ideas and methodology.

In addition, some of the work was apparently covered by a copyright agreement.

Both papers were co-authored by the same three people. The idea theft came to light after one of the co-authors received a complaint from her former supervisor, prompting her to contact the publisher to resolve the issue.

Wendy Hurp, executive publisher of Food Science at Elsevier, which publishes the two journals, provided some additional background on what happened: Read the rest of this entry »

Plant scientist logs 4 more notices over figure errors

without comments

Researchers in China have retracted a paper and corrected three others in a plant journal, citing problems with multiple figures.

Lixin Zhang, from the Chinese Academy of Sciences in Beijing, is corresponding author on all four papers, published by Plant PhysiologyWe’ve reported on three retractions and two corrections from Lixin Zhang and some of the same co-authors, bringing Zhang’s total to five retractions and four corrections, by our count.

According to the retraction notice, the authors agreed to pull the article because of figure-related “irregularities and inappropriate data handling” — but despite these issues, they remain confident that their conclusions are still valid.

Here’s the latest retraction notice, issued this February, for “Cooperation of LPA3 and LPA2 Is Essential for Photosystem II Assembly in Arabidopsis:”  Read the rest of this entry »

Physics paper’s results off by factor of 100

without comments

Researchers from China have retracted a physics paper after realizing an error led them to report results that were nearly 100 times too large.

What’s more, the authors omitted key findings that would enable others to reproduce their experiments.

According to the notice, the authors used a value to calculate a feature of electrons—called mobility—that “was approximately 100 times too small,” which led to results that were “100 times too large.” The notice also details several gaps in the presentation of experimental results, which preclude others from duplicating the experiments.

Here’s the retraction notice for “Bulk- and layer-heterojunction phototransistors based on poly[2-methoxy-5-(2′-ethylhexyloxy-p-phenylenevinylene)] and PbS quantum dot hybrids:” Read the rest of this entry »

Why don’t the raw data match what was reported in a chemistry paper?

without comments

Chemistry researchers in China have retracted their 2016 paper after reporting that the raw data did not match what they presented in the article.

The authors were attempting to develop a method to produce large amounts of a high-quality two-dimensional form of antimonene, a prized crystal structure that has been notoriously difficult to synthesize reliably.

They were successful, according to the paper, achieving “a large quantity of few-layer antimonene” and demonstrating its “exact atomical structure” and properties.

But they may have spoken too soon. Read the rest of this entry »

“Knowledgeable informant” outs researchers for falsifying data

with 2 comments

A pathology journal has retracted a 2015 paper from researchers in China after concluding the authors had falsified and copied some of the data and text.

According to the notice, a “knowledgeable informant” told the journal about the overlap and “fraudulent” aspects of the paper, which the editors were able to confirm. The journal retracted the paper last month.

Here’s the retraction notice for “Genistein attenuates glucocorticoid-induced bone deleterious effects through regulation Eph/ephrin expression in aged mice:”

Read the rest of this entry »